MedTrace Logo

Impact of Hypovitaminosis D on Bone Disease in HIV Infected Patients

NCT02351284 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2022-10-18

No results posted yet for this study

Summary

To determine the prevalence of hypovitaminosis D in HIV infected patients, and the consequences on secondary hyperparathyroidism, and bone mineral density (BMD). Also, to establish the improvement in vitamin D status, parathyroid hormone (PTH) and BMD, in case of receiving vitamin D supplementation, during a follow up period of at least 1 year.

Conditions

  • Hypovitaminosis D

Interventions

OTHER

Measurement

Measurement of vitamin D, PTH, and BMD changes in HIV-infected patients

Sponsors & Collaborators

  • Jose L. Casado

    lead NETWORK

Principal Investigators

  • Sara Bañon, MD · Ramon y Cajal Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-12
Primary Completion
2022-11-30
Completion
2022-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02351284 on ClinicalTrials.gov